Terilyn J. Monroe, Chief People Officer at Guardant Health, Inc. (GH), sold 109,534 shares at $106.90 ($11.6M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($11.6M) by Chief People Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.33 | 18,576 | $2.0M | 16.9% |
| 2 | $105.33 | 18,576 | $2.0M | 16.9% |
| 3 | $105.33 | 1,923 | $203K | 1.7% |
| 4 | $105.33 | 1,923 | $203K | 1.7% |
| 5 | $106.15 | 23,974 | $2.5M | 21.9% |
| 6 | $106.15 | 23,974 |
| $2.5M |
| 21.9% |
| 7 | $106.18 | 2,444 | $260K | 2.2% |
| 8 | $106.18 | 2,444 | $260K | 2.2% |
| 9 | $106.90 | 6,786 | $725K | 6.3% |
| 10 | $106.90 | 6,786 | $725K | 6.3% |
| 11 | $107.03 | 800 | $86K | 0.7% |
| 12 | $107.85 | 664 | $72K | 0.6% |
| 13 | $107.85 | 664 | $72K | 0.6% |
| Total | $105.96 avg | 109,534 | $11.6M | 100% |
| Filing → |
| GH | SELL | 2026-01-22 | $978K | — | Filing → |
| GH | SELL | 2026-01-09 | $1.1M | — | Filing → |